GO TEAM: Glucose Optimization Through Technology Assisted Management
NCT ID: NCT06074458
Last Updated: 2025-07-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
60 participants
INTERVENTIONAL
2024-01-29
2026-11-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Glu-COACH: a Peer-mentoring Intervention to Reduce Disparities in Continuous Glucose Monitor (CGM) Use
NCT06171412
Can Glucose Monitoring Improve (CGMi Study)
NCT01472159
T1DTechCHW: Enhancing the Community Health Worker Model to Promote Diabetes Technology Use in Young Adults From Underrepresented Minority Groups
NCT05211869
Health Behavior Intervention for Adults With Type 1 Diabetes
NCT05823142
High Risk Youth With Poorly-controlled Diabetes
NCT03680079
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard of Care
Participants in this arm follow standard of care procedures.
No interventions assigned to this group
Diabetes Dashboard and Community Health Worker
Participants diabetes technology devices will be linked to a remote patient monitoring dashboard and will have access to a Smartphone application, as well as scheduled and as needed visits with a community health worker.
Glucosano
Glucosano is a remote patient monitoring diabetes dashboard with a patient facing Smartphone application
Community Health Worker diabetes technology coach
Community Health Workers will work with participants as a diabetes technology coach during scheduled and as needed visits
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Glucosano
Glucosano is a remote patient monitoring diabetes dashboard with a patient facing Smartphone application
Community Health Worker diabetes technology coach
Community Health Workers will work with participants as a diabetes technology coach during scheduled and as needed visits
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Clinical diagnosis of T1D requiring treatment with insulin at the time of consent
* Not currently (within the past 3 months) using an automated insulin delivery system \\
* Willingness to wear a continuous glucose monitor for 10 days at 3 different time points, and willingness to consider use of a personal continuous glucose monitor
Exclusion Criteria
* Completed high school
* Non-English speaking guardians
* Automated insulin delivery system use within the past 3 months
* Custody of children and family services
8 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
KeborMed
UNKNOWN
Sarah MacLeish
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sarah MacLeish
Associate Professor of Pediatrics
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospitals Cleveland Medical Center
Cleveland, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Study20230860
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.